Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Wintermute analyst: Bitcoin is short-term oversold, but the sideways trend may continue in the near future

Wintermute analyst: Bitcoin is short-term oversold, but the sideways trend may continue in the near future

Odaily星球日报Odaily星球日报2025/12/19 16:20
Show original

According to Odaily, Wintermute trading strategist Jasper De Maere stated that bitcoin is currently short-term oversold, but the sideways trend may continue, and it is likely to fluctuate within the $86,000 to $92,000 range for now. He advised against over-interpreting technical indicators at this stage and expects more profit-taking in the next two weeks, mainly driven by year-end portfolio adjustments and tax considerations. He anticipates that bitcoin's sideways movement will persist until a new catalyst emerges, one of which could be the large-scale options expiry in late December. Although it is too early to assert that the market has bottomed, signs of a bottom are beginning to appear. (CoinDesk)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11